Oragenics (OGEN) Shares Issued (2010 - 2026)
Oragenics' (OGEN) quarterly Shares Issued came in at $1.1 million in Q1 2026, up 46.46% YoY from $734888.0 in Q1 2025, and little changed on a QoQ basis from $1.1 million in Q4 2025.
Oragenics (OGEN) Shares Issued (2010 - 2026) Analysis & Trends
Oragenics (OGEN) has 15 years of Shares Issued data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Shares Issued rose 46.46% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 46.46% YoY) and the FY2025 annual result came in at $1.1 million, up 3146.85% from the prior year.
- Shares Issued held at $1.1 million in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $8.9 million in Q3 2022 to a low of $22844.0 in Q2 2025.
- A 5-year average of $1.8 million and a median of $244733.0 in 2023 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2023 — Shares Issued plunged 98.94% — and 2025, when it surged 3146.85%.
- Tracing OGEN's Shares Issued over 5 years: stood at $139090.0 in 2022, then surged by 75.95% to $244733.0 in 2023, then slumped by 86.45% to $33150.0 in 2024, then soared by 3146.85% to $1.1 million in 2025, then retreated by 0.0% to $1.1 million in 2026.
- The last three Shares Issued figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $24012.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Oragenics | 2.35 Mn | 2.35 Mn | - | 1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.08 Mn |
| Jun 30, 2026 | 1.08 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | 24,012.00 |
| Sep 30, 2025 | 24,012.00 |
| Jun 30, 2025 | 22,844.00 |
| Jun 30, 2025 | 22,844.00 |
| Mar 31, 2025 | 734,888.00 |
| Mar 31, 2025 | 734,888.00 |
| Dec 31, 2024 | 33,150.00 |
| Dec 31, 2024 | 33,150.00 |
| Sep 30, 2024 | 1.02 Mn |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 186,370.00 |
| Jun 30, 2024 | 186,370.00 |
| Mar 31, 2024 | 179,514.00 |
| Mar 31, 2024 | 179,514.00 |